Product Highlight - ILUMETRI

19 Sep 2025
Product Highlight - ILUMETRI
Powering for the long road ahead with Ilumetri®

• ILUMETRI® demonstrate rapid onset of action1

• Reassuring long-term efficacy and safety2,3,4

• High drug retention rate over 5 years5,6

References:
1. Data on file. Sun Pharmaceutical Industries.
2. Augustin M, et al. EMJ Dermatol 2021;9[Suppl 1]:2-11.
3. Thaci D, et al. Br J Dermatol 2021;185:323-334.
4. Reich K, et al. Lancet 2017;390:276-288.
5. Breen I, et al. J Am Acad Dermatol 2023;89(Suppl):AB119. 2.
6. Yi Xue Jie. Highlights of the 2023 AAD Annual Meeting on advances in psoriasis - Interview with Professor Zheng Jie. https://mp.weixin.qq.com/s/xK0sgPW8udNuphVm70dFsQ. Accessed 07 January 2025.

RXILIENT MEDICAL (HONG KONG) LIMITED
Unit 2106, 21/F, Island Place Tower, No. 510 King's Rd, North Point
Tel: (+852) 2369 3889 Ext (127)
Email: enquiry_hk@rxilient.com

Related MIMS Drugs